hVIVO plc (formerly Open Orphan plc)
Company Profile
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Latest Company Summary
Investor Access
Matthew Walls, Chief Executive Officer, and Paul Foulger, Chief Financial Officer, will provide a live presentation relating to the results via the Investor Meet Company platform on Thursday, 2 October 2025 at 11.00am BST.
Investors can sign up to Investor Meet Company for free and add to meet GENinCode here
| Event | Date |
| Year End | 31 December |
| Half Year End | 30 June |
| Preliminary Results* | April |
| Interim Results* | September |
| AGM* | May |
* Months based on previous announcements of this kind
